Türkiye's Leading Pharmaceutical Company Expands its Portfolio and Presence in Consumer Health

ABDİ İBRAHİM STRIKES DEAL WITH ARONPHARMA

Abdi İbrahim, Türkiye's leading pharmaceutical company and a strong player in consumer health products, is collaborating with Aronpharma, a key European company specializing in innovative food supplements for their innovative brand Berroxin.

Abdi İbrahim has acquired sales and distribution rights in Türkiye for products that help support the immune system under the Berroxin brand of Aronpharma, which offers innovative food supplement products. The portfolio will be launched in the Turkish market starting in 2023 with the assurance of Abdi İbrahim.

Berroxin contains the highest available concentration of Fenactive®, a complex blend of aronia and elderberry extracts.

"We will continue to invest to reinforce our strength and vision in consumer health"

Abdi İbrahim Chairman Nezih Barut emphasized that the consumer health products market was a crucial focus in Abdi İbrahim's future vision, which has been dedicated to healing lives for 111 years. He highlighted the value of their collaborations in this field, stating; “We are excited to introduce Turkish consumers to Berroxin brand products. With this deal, we are presenting a highly reliable and innovative portfolio to the competitive and intense market. This collaboration is an indication of our determination to continue the same success in the field of consumer health as we do in prescription products. Additionally, it is a significant step that will expedite our progress toward international goals in this field. In the coming periods, we will continue to invest relentlessly in strengthening our power and vision in consumer health.”